In summary, this study provide evidence that the -844 G/A PAI-1 polymorphism is related with the risk of developing MetS, obesity and atherogenic dyslipidemia, and the HindIII C/G PAI-1 polymorphism is associated with increased total cholesterol levels, which contributes to the pathogenesis of MetS. Here, SERPINE1 is linked to metabolic syndrome.